More importantly, we initially demonstrated that SIRT3 expression levels are closely associated with survival time of NSCLC patients, that is, the higher expression of SIRT3 leading the shorter survival time in NSCLC patients. The gene discussed is SIRT3; the disease is non-small cell lung carcinoma.